Position in GRAL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,059,637
+$972,135 QoQ
Shares Held
30,169
+43.4% QoQ
Ownership
0.068%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#81
of 374 holders
Holding Since
Sep 2024
8 quarters on record
Voting authority
Sole 95%
Shared 0%
None 5%
Common Shares in GRAL Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026JONES FINANCIAL COMPANIES LLLP holds $915,608,637 across 32 Diagnostics & Research names. GRAL ranks #17 (0.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
463,287 | $232,273,570 | |
| 2 | DHR |
Danaher Corp /De/
|
843,981 | $160,761,500 | |
| 3 | LH |
Labcorp Holdings Inc.
|
401,964 | $112,549,920 | |
| 4 | WAT |
Waters Corp /De/
|
290,936 | $109,112,636 | |
| 5 | MEDP |
Medpace Holdings, Inc.
|
191,268 | $101,293,619 | |
| 6 | QGEN |
Qiagen N.V.
|
1,607,803 | $62,865,097 | |
| 7 | CRL |
Charles River Laboratories International, Inc.
|
172,385 | $39,095,193 | |
| 8 | IDXX |
Idexx Laboratories Inc /De
|
57,674 | $30,361,900 |
All Filings in GRAL
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,059,637 | 30,169 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,087,502 | 21,043 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $711,338 | 8,311 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $266,617 | 4,509 | Shares | Sole | 2025-11-04 | |
| 2025-06-30 | $77,078 | 1,499 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $26,025 | 1,019 | Shares | Sole | 2025-05-28 | |
| 2024-12-31 | $14,387 | 806 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $10,237 | 744 | Shares | Sole | 2024-11-12 | |
| No filing history on record for this holder in this stock. | ||||||